Synapse - Radiology, Department of

Results (14)

Noninvasive imaging of CD4(+) T cells in humanized mice

Journal Article

Nagle, V. L.; Hertz, C. A. J.; Henry, K. E.; Graham, M. S.; Campos, C.; Pillarsetty, N.; Schietinger, A.; Mellinghoff, I. K.; Lewis, J. S.
Molecular Cancer Therapeutics (2022)

Fulltext@MSK | Save

Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity

Journal Article

Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
Molecular Cancer Therapeutics (2022)

Fulltext@MSK | Save

Intraperitoneal pretargeted radioimmunotherapy for colorectal peritoneal carcinomatosis

Journal Article

Chandler, C. S.; Bell, M. M.; Chung, S. K.; Veach, D. R.; Fung, E. K.; Punzalan, B.; Burnes Vargas, D.; Patel, M.; Xu, H.; Guo, H. F.; more...
Molecular Cancer Therapeutics (2022)

Fulltext@MSK | Save

ERK inhibition improves anti-PD-L1 immune checkpoint blockade in preclinical pancreatic ductal adenocarcinoma

Journal Article

Henry, K. E.; Mack, K. N.; Nagle, V. L.; Cornejo, M.; Michel, A. O.; Fox, I. L.; Davydova, M.; Dilling, T. R.; Pillarsetty, N.; Lewis, J. S.
Molecular Cancer Therapeutics (2021)

Fulltext@MSK | Save

Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers

Meeting Abstract

Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
Molecular Cancer Therapeutics (2019)

Fulltext@MSK | Save

Overcoming drug resistance to Trk inhibition by rational combination of entrectinib and trametinib: From bench to bedside

Meeting Abstract

Wei, G.; Maneval, E. C.; Esquibel, V.; Berger, M. F.; Haque, S.; Patel, R.; Walsh, C.; Hornby, Z.; Multani, P.; Li, G.
Molecular Cancer Therapeutics (2017)

Fulltext@MSK | Save

Establishment of the in vivo efficacy of pretargeted radioimmunotherapy utilizing inverse electron demand Diels-Alder click chemistry

Journal Article

Houghton, J. L.; Membreno, R.; Abdel-Atti, D.; Cunanan, K. M.; Carlin, S.; Scholz, W. W.; Zanzonico, P. B.; Lewis, J. S.; Zeglis, B. M.
Molecular Cancer Therapeutics (2017)

Fulltext@MSK | Save

Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex

Journal Article

Cheal, S. M.; Xu, H.; Guo, H. F. ; Zanzonico, P. B.; Larson, S. M.; Cheung, N. K.
Molecular Cancer Therapeutics (2014)

Fulltext@MSK | Save

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer

Journal Article

Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A. C. W.; Findlay, D. M.; Evdokiou, A.
Molecular Cancer Therapeutics (2009)

Fulltext@MSK | Save

PCK3145, a novel multitargeted signalling agent for the treatment of castrate metastatic prostate cancer (CMPC)

Meeting Abstract

Slovin, S. F.; Dulude, H.; Pancha, C.; Czanny, M.; Curley, T.; Morris, M.; Rathkopf, D.; Schwartz, L.; Heller, G.; Scher, H. I.
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save